Tenaya Therapeutics to Announce New Interim Data from MyPEAK™-1 Phase 1b/2 Trial of TN-201 for Adults with MYBPC3-Associated HCM on Wednesday, June 3, 2026
Management to host webcast on Wednesday, June 3 at 8:00 a.m. ET Management to host webcast on Wednesday, June 3 at 8:00 a.m. ET
Management to host webcast on Wednesday, June 3 at 8:00 a.m. ET Management to host webcast on Wednesday, June 3 at 8:00 a.m. ET
Summary aggregated from GlobeNewswire's public RSS feed. The full reporting belongs to GlobeNewswire — please read it on their site.